Jin Xing Qi

Chairman at HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD

Net worth: 1 642 M $ as of 2024-03-30

62 year

17 connections

Finance

Consumer Services

Miscellaneous

Profile

Jin Xing Qi founded Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Presently, he is Chairman of Hangzhou Binjiang Real Estate Group Co., Ltd. and Chairman at Hangzhou Pute Equity Investment Co. Ltd. Mr. Qi is also on the board of Hangzhou Binjiang Investment Holding Co., Ltd. and Hangzhou Xincheng Time Square Real Estate Co., Ltd. and Vice President of Zhejiang Management Research. In the past Mr. Qi held the position of Director at Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Jin Xing Qi received an MBA from Zhejiang University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
HANGZHOU BINJIANG REAL ESTATE GROUP CO., LTD. CLASS A 55.93%	2023-09-29	1,505,912,522 ( 55.93% )	1 386 M $	2024-03-30
HANGZHOU BINJIANG REAL ESTATE GROUP CO., LTD. 64.95%	2023-09-29	278,698,950 ( 64.95% )	256 M $	2024-03-30

Jin Xing Qi active positions

Companies	Position	Start
HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD	Chairman	2002-12-31
Zhejiang Management Research	Corporate Officer/Principal	2010-02-23
Hangzhou Pute Equity Investment Co. Ltd.	Chairman	2011-04-06
Hangzhou Binjiang Investment Holding Co., Ltd. Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding private company based in Hangzhou, China.	Director/Board Member	-
Hangzhou Xincheng Time Square Real Estate Co., Ltd. Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The private company is based in Hangzhou, China.	Director/Board Member	-

All active positions of Jin Xing Qi

Former positions of Jin Xing Qi

Companies	Position	End
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China.	Founder	-

See the detail of Jin Xing Qi's experience

Training of Jin Xing Qi

Zhejiang University

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jin Xing Qi's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD	Finance

Private companies	5
Hangzhou Binjiang Investment Holding Co., Ltd. Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding private company based in Hangzhou, China.	Miscellaneous
Zhejiang Management Research
Hangzhou Xincheng Time Square Real Estate Co., Ltd. Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The private company is based in Hangzhou, China.	Finance
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China.	Health Technology
Hangzhou Pute Equity Investment Co. Ltd.	Finance

See company connections